ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,374Medicare Part D Prescriptions Filled, Including Refills

Rank: 232 out of 2588

$654K Total Retail Price of All Prescriptions

Rank: 273 out of 2588

402 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,036 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 593 470 1 1
FUROSEMIDE 480 436 2 5
WARFARIN SODIUM 442 411 3 10
AMLODIPINE BESYLATE 419 370 4 4
LISINOPRIL 394 300 5 3
METOPROLOL TARTRATE 377 322 6 9
OMEPRAZOLE 285 254 7 6
LEVOTHYROXINE SODIUM 284 248 8 2
METFORMIN HCL 256 194 9 8
POTASSIUM CHLORIDE 225 185 10 15
DONEPEZIL HCL 211 203 11 22
QUETIAPINE FUMARATE 204 163 12 74
NAMENDA 195 195 13 32
FAMOTIDINE 187 161 14 36
GABAPENTIN 179 141 15 18
HYDROCHLOROTHIAZIDE 176 156 16 13
HEPARIN SODIUM 164 144 17 79
TRAMADOL HCL 160 149 18 19
METOPROLOL SUCCINATE 152 102 19 12
CLONIDINE HCL 150 117 20 54
LANTUS 129 126 21 47
HYDROCODONE-ACETAMINOPHEN 128 109 S3 22 7
SERTRALINE HCL 127 94 23 26
ATORVASTATIN CALCIUM 126 105 24 11
RISPERIDONE 125 81 25 57
CLOPIDOGREL 111 103 26 30
TRAZODONE HCL 97 66 27 61
CARVEDILOL 97 82 27 20
PANTOPRAZOLE SODIUM 96 80 29 28
HYDRALAZINE HCL 95 78 30 53
GLIPIZIDE 94 81 31 44
RAMIPRIL 90 90 32 111
LEVETIRACETAM 89 79 33 90
POLYETHYLENE GLYCOL 3350 88 42 34 55
SEROQUEL 85 65 35 186
BENZTROPINE MESYLATE 83 27 R 36 107
ESCITALOPRAM OXALATE 82 72 37 68
DIVALPROEX SODIUM 79 56 38 89
PLAVIX 78 70 39 43
MIRTAZAPINE 75 58 40 63
CIPROFLOXACIN HCL 70 52 41 82
ZOLPIDEM TARTRATE 70 67 41 24
DIGOXIN 66 64 43 38
IBUPROFEN 65 27 44 62
SANTYL 65 46 44 160
ALLOPURINOL 64 58 46 33
CITALOPRAM HBR 63 58 47 27
CARBAMAZEPINE 62 41 48 146
METOCLOPRAMIDE HCL 59 38 49 136
TAMSULOSIN HCL 59 47 49 23
CARBIDOPA-LEVODOPA 58 45 51 83
LACTULOSE 56 24 52 135
KLOR-CON M10 55 55 53 139
ATENOLOL 53 40 54 14
ALENDRONATE SODIUM 53 38 54 21
NOVOLIN R 51 47 56 175
CLOZAPINE 51 0 56 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.